Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial

Table 2 Rates of Gram-positive resistant phenotypes collected from Latin America by country, 2004–2015

Country	Methicillin-resistant S. aureus		Penicillin-resistant S. pneumoniae		Vancomycin-resistant E. faecium		Vancomycin-resistant E. faecalis
Country	n/N	%	n/N	%	n/N	%	n/N	%
Central America
Guatemala	226/336	67.3	0/15	0.0	6/29	20.7	0/116	0.0
Honduras	30/62	48.4	2/10	20.0	1/10	10.0	0/31	0.0
Panama	89/224	39.7	11/108	10.2	2/11	18.2	0/114	0.0
Rest of Latin America
Argentina	454/947	47.9	35/412	8.5	60/115	52.2	2/408	0.5
Brazil	141/290	48.6	12/112	10.7	34/44	77.3	19/133	14.3
Chile	254/410	62.0	24/146	16.4	33/59	55.9	4/163	2.5
Colombia	261/653	40.0	25/187	13.4	33/86	38.4	5/314	1.6
Mexico	547/1243	44.0	73/350	20.9	55/175	31.4	2/565	0.4
Venezuela	136/265	51.3	14/81	17.3	9/38	23.7	1/121	0.8
All Latin America^a	2202/4563	48.3	198/1436	13.8	235/576	40.8	33/2004	1.6

^aIncludes all countries in Latin America that participated in T.E.S.T. Individual data for El Salvador, Nicaragua, Jamaica and Puerto Rico not present as contributed isolates in ≤2 years

ISSN: 1476-0711